Barclays PLC Eli Lilly & CO Call Options Transaction History

Barclays PLC

$288 Billion
Q1 2024

Call Options

20 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2024 May 15, 2024	SELL	$592.2 - $792.28 $23.5 Million - $31.4 Million	-39,600 Reduced 91.24%	3,800 $2.96 Million
Q4 2023 Feb 15, 2024	BUY	$525.19 - $619.13 $22.8 Million - $26.9 Million	43,400 New	43,400 $25.3 Million
Q1 2023 May 04, 2023	SELL	$310.63 - $364.82 $26.9 Million - $31.6 Million	-86,600 Reduced 62.57%	51,800 $17.8 Million
Q4 2022 Feb 13, 2023	BUY	$321.55 - $374.67 $44.5 Million - $51.9 Million	138,400 New	138,400 $50.6 Million
Q4 2021 Feb 14, 2022	BUY	$224.85 - $279.04 $1.66 Million - $2.06 Million	7,400 Added 284.62%	10,000 $2.76 Million

Q1 2021 May 13, 2021	SELL	$164.32 - $212.72 $4.68 Million - $6.06 Million	-28,500 Reduced 91.64%	2,600 $486,000
Q4 2020 Feb 11, 2021	BUY	$130.46 - $172.63 $3.55 Million - $4.7 Million	27,200 Added 697.44%	31,100 $5.25 Million
Q3 2020 Nov 12, 2020	SELL	$146.22 - $169.13 $4.61 Million - $5.33 Million	-31,500 Reduced 88.98%	3,900 $577,000
Q2 2020 Aug 12, 2020	SELL	$136.42 - $164.18 $26.2 Million - $31.6 Million	-192,200 Reduced 84.45%	35,400 $5.81 Million
Q1 2020 May 13, 2020	BUY	$119.05 - $147.35 $16 Million - $19.7 Million	134,000 Added 143.16%	227,600 $31.6 Million
Q4 2019 Feb 10, 2020	SELL	$106.92 - $132.43 $4.41 Million - $5.46 Million	-41,200 Reduced 30.56%	93,600 $12.3 Million
Q3 2019 Nov 14, 2019	BUY	$106.79 - $116.16 $5.97 Million - $6.49 Million	55,900 Added 70.85%	134,800 $15.1 Million
Q2 2019 Aug 14, 2019	SELL	$110.79 - $129.32 $76.9 Million - $89.8 Million	-694,200 Reduced 89.79%	78,900 $8.74 Million
Q1 2019 May 15, 2019	BUY	$111.31 - $131.02 $81.7 Million - $96.2 Million	734,200 Added 1887.4%	773,100 $100 Million
Q4 2018 Feb 14, 2019	SELL	$105.9 - $118.64 $13.4 Million - $15.1 Million	-127,000 Reduced 76.55%	38,900 $4.5 Million
Q3 2018 Nov 14, 2018	SELL	$85.86 - $107.31 $6.1 Million - $7.63 Million	-71,100 Reduced 30.0%	165,900 $17.8 Million
Q2 2018 Aug 14, 2018	SELL	$75.7 - $86.88 $408,780 - $469,152	-5,400 Reduced 2.23%	237,000 $20.2 Million
Q1 2018 May 15, 2018	BUY	$74.21 - $87.6 $9.77 Million - $11.5 Million	131,700 Added 118.97%	242,400 $18.8 Million
Q4 2017 Feb 14, 2018	SELL	$81.94 - $87.89 $3.87 Million - $4.15 Million	-47,200 Reduced 29.89%	110,700 $9.35 Million
Q3 2017 Nov 14, 2017	BUY	$77.07 - $85.54 $12.2 Million - $13.5 Million	157,900	157,900 $13.5 Million

Others Institutions Holding LLY

# of Institutions

3,712

Shares Held

738M

Call Options Held

7.09M

Put Options Held

7.24M

Lilly Endowment Inc Indianapolis, IN

98.9M
Shares

$81.1 Billion
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

72.7M
Shares

$59.7 Billion
1.14% of portfolio
Black Rock Inc. New York, NY

65.3M
Shares

$53.5 Billion
1.2% of portfolio
Pnc Financial Services Group, Inc. Pittsburgh, PA

51.4M
Shares

$42.2 Billion
27.92% of portfolio
State Street Corp Boston, MA

34.3M
Shares

$28.1 Billion
1.21% of portfolio

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $779B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Account